I"<p><a href="https://profiles.stanford.edu/teri-klein"><strong>Teri KLEIN</strong></a> is a Professor in the Departments of Biomedical Data Science and Medicine (BMIR) at Stanford University and Principal Investigator of <a href="https://www.pharmgkb.org/"><strong>PharmGKB</strong></a>, <a href="https://cpicpgx.org/"><strong>CPIC</strong></a>, <a href="https://pharmcat.org/"><strong>PharmCAT</strong></a> and <a href="https://clinicalgenome.org/about/organizations/stanford-university/"><strong>ClinGen</strong></a>. She is internationally recognized for her work in pharmacogenomics, personalized medicine, computational biology and bioinformatics, and her research focus is currently centered on the development of <a href="https://www.pharmgkb.org/"><strong>PharmGKB</strong></a>, clinical pharmacogenomic dosing guidelines, clinical genomics and the annotation of the human genome, and the structural basis of disease. She has graciously been a friend and mentor to the SCOTT LAB for ~10 years, with no end in the foreseeable future.</p>
:ET